2001
DOI: 10.1053/sarh.2001.19958
|View full text |Cite
|
Sign up to set email alerts
|

Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): A concomitant disease or a feature of FMF?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
101
0
6

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 134 publications
(108 citation statements)
references
References 17 publications
1
101
0
6
Order By: Relevance
“…The main renal features will therefore be hypertension, mild hematuria and proteinuria. However, it is interesting to note that in patients with familial Mediterranean fever, a number of ANCA(−) patients have been defined with both glomerulonephritis and proven vasculitis of medium-sized vessels, suggesting an overlap of these groups [31].…”
Section: Medium-vessel Vasculitismentioning
confidence: 99%
“…The main renal features will therefore be hypertension, mild hematuria and proteinuria. However, it is interesting to note that in patients with familial Mediterranean fever, a number of ANCA(−) patients have been defined with both glomerulonephritis and proven vasculitis of medium-sized vessels, suggesting an overlap of these groups [31].…”
Section: Medium-vessel Vasculitismentioning
confidence: 99%
“…PAN in FMF patients has unique features: It appears at an earlier age than classic PAN, perirenal hematoma appears in up to 50% of patients, some have overlap features of PAN and microscopic PAN, and the prognosis is relatively good 9 . Other than reports of these 2 diseases, there are no large epidemiological studies suggesting that non-amyloid glomerular disease is more frequent in FMF patients than in the general population.…”
Section: Rheumatologymentioning
confidence: 99%
“…The disease is characterized by recurrent episodes of fever, pleuritis, peritonitis, synovitis and pericarditis. The major complication of FMF is the development of renal amyloidosis leading to end stage renal failure and it remains the leading cause of FMF-related mortality (5)(6)(7)(8). Colchicine was found to be an effective drug in the treatment of FMF (9).…”
Section: Introductionmentioning
confidence: 99%